WEBULL
WebtradeDownload

Teladoc Health (TDOC) Could Be 58% Undervalued As A New CFO Takes Over

Simply Wall St · 1d ago

Why Teladoc Health Brought In A New CFO

Teladoc Health (TDOC) has appointed Michael Grasher as Chief Financial Officer, effective 31 August 2026, giving investors a fresh focal point for assessing the company’s financial leadership and capital allocation plans.

The Teladoc Health share price has eased in the past day and is down about 11% over the past month, while the 1 year total shareholder return has fallen roughly 19% and the 5 year total shareholder return has declined about 95%, so momentum has been weak and the CFO appointment lands against a backdrop of prolonged pressure on the equity story.

Compare Teladoc Health’s reset with a curated set of beaten-down opportunities using the 49 high quality undervalued stocks that screens for quality balance sheets and cash flows under pressure.

After a fresh selloff and a new finance chief waiting in the wings, Teladoc Health sits at a crossroads. Does the current valuation compensate you enough for the execution and profitability risks still on the table?

Most Popular Narrative: 58.1% Undervalued

Against a last close of $6.28, the most followed Teladoc Health narrative pins fair value at $15.00, so the gap to that view is wide.

Despite the market narrative of a failing pandemic stock, Teladoc’s underlying financial engine tells a radically different story.

Teladoc is a cash-generative healthcare utility with $750M+ in hard cash protecting the downside, annual free cash flow and an expanding insurance-reimbursed mental health model.

Read the complete narrative.

Curious how that $15.00 figure is built? The valuation leans heavily on free cash flow resilience, an insurance shift inside BetterHelp and a profit multiple usually linked to higher quality growth stories.

Result: Fair Value of $15.00 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

Still, Teladoc Health’s narrative can break if BetterHelp’s insurance pivot compresses margins or if telehealth rivals continue to force higher marketing spend.

Find out about the key risks to this Teladoc Health narrative.

Next Steps

If the Teladoc Health story so far feels conflicted, use that tension as a prompt to move quickly and review the full risk and reward breakdown. Then weigh those 3 key rewards and 2 important warning signs.

Looking For More Ideas Beyond Teladoc Health?

If Teladoc Health has sharpened your focus on valuation and risk, do not stop here. Broaden your watchlist now so you are not playing catch-up later.

  • Target resilient cash generators by reviewing the 49 high quality undervalued stocks, which highlights businesses combining solid cash flows with prices that may not fully reflect their fundamentals.
  • Prioritise sleep-at-night holdings through the 83 resilient stocks with low risk scores, which surfaces companies with steadier risk profiles relative to the wider market.
  • Spot early opportunities before the crowd by scanning the 17 high quality undiscovered gems, which filters for quality fundamentals hiding behind low investor attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.